Lysophosphatidic Acid (LPA) Screening Service
The Lysophosphatidic Acid (LPA) Screening Service uses the LPA ELISA II (cat# K-2800s) to quantify LPA in biological samples. LPA is a serum-derived phospholipid involved in diverse cellular processes such as cell proliferation, chemotaxis, platelet aggregation, wound healing, angiogenesis, tumor invasion, and smooth muscle contraction. Recent research indicates LPA may play a significant role in the pathophysiology of cancer and may be used as a biomarker for ovarian cancer. Several literature citations indicate plasma LPA levels are elevated in ovarian cancer patients.
- Echelon has 25 years of ELISA expertise and 15 years experience in the LPA field.
- Your samples are cataloged and stored according to your requirements.
- The LPA Screening Service will run each sample in duplicate.
- Results are provided as an average of the duplicate points in μM LPA.
- Usually, results are provided 2 weeks from receipt of samples. We can accommodate tighter schedules if needed.
Contact us for a quote on your custom assay service.
LPA is quantified using the LPA ELISA II (cat # K-2800s). The LPA ELISA II is a sensitive and robust method for quantification of LPA in a competitive ELISA format. The concentration of LPA in the sample is determined using a standard curve of known amounts of C18:3 LPA.
Assay Range: 0.064 μM to 1,000 μM LPA
Inter-assay CV: 8.9-15.33%
Intra-assay CV: 6.5-8.7%
Fill out the form below to receive a full quote for this service.
Citations listed are from the LPA ELISA II (catalog number K-2800S).